Global challenges in pediatric oncology

Current Opinion in Pediatrics

Volumn 25, Issue 1, 2013, Pages 3-15

  Rodriguez Galindo, Carlos ^a,b   Friedrich, Paola ^a,b   Morrissey, Lisa ^a   Frazier, Lindsay ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

global health; low income and middle income countries; pediatric cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ARID5B PROTEIN; CYCLOPHOSPHAMIDE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PROTEIN; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CAPACITY BUILDING; CHILDHOOD CANCER; CHILDHOOD MORTALITY; COMORBIDITY; DIAGNOSTIC ERROR; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EVENT FREE SURVIVAL; GENETIC VARIABILITY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH SERVICES RESEARCH; HEMATOLOGIC MALIGNANCY; HEREDITY; HUMAN; MALNUTRITION; MULTIMODALITY CANCER THERAPY; NURSING CARE; ONCOLOGY NURSING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PERSONNEL; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RACE DIFFERENCE; RECURRENCE RISK; RETINOBLASTOMA; REVIEW; SKULL IRRADIATION; SOCIOECONOMICS; TREATMENT REFUSAL;

CANCER CARE FACILITIES; CHILD; CHILD HEALTH SERVICES; DEVELOPING COUNTRIES; HUMANS; INTERNATIONAL COOPERATION; MEDICAL ONCOLOGY; MEDICALLY UNDERSERVED AREA; NEOPLASMS; PROGRAM DEVELOPMENT; WORLD HEALTH;

EID: 84873855403     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32835c1cbe     Document Type: Review

References (83)

1. Brown M, Goldie S, Draisma G, et al. Health service interventions for cancer control in developing countries. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. II ed. Washington, DC: World Bank; 2006. Chapter 29. Available from http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK11756/. [Accessed October 2012
2. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet 2010; 376: 1186-1193
3. Beaulieu N, Bloom D, Bloom R, Stein R. Breakaway: The global burden of cancer - Challenges and opportunities A report from the Economist Intelligence Unit, 2009. http://livestrongblog.org/GlobalEconomicImpact.pdf. [Accessed October 2012] An in-Depth analysis of the cancer burden globally
4. Kellie SJ, Howard SC. Global child health priorities: What role for paediatric oncologists? Eur J Cancer 2008; 44:2388-2396
5. Union for International Cancer Control. The World Cancer Declaration. http://wwwuiccorg/world-cancer-Declaration. [Accessed October 2012
6. World Health Organization. MFG4: Child mortality, 1990-2011. Under-five mortality rate, 2011. http://gamapserver.who.int/gho/interactive-charts/MDG4/ atlas.html. [Accessed October 2012
7. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-Income or mid-Income countries receiving My Child Matters support: A descriptive study. Lancet Oncol 2008; 9:721-729
8. Pé rez-Cuevas R, Doubova SV, Zapata-Tarres M, et al. Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico. Pediatr Blood Cancer 2013; 60:196-203
9. Curado M, Voti L, Sortino-Rachou A. Cancer registration data and quality indicators in low and middle income countries: Their interpretation and potential use for the improvement of cancer care. Cancer Causes Control 2009; 20:751-756
10. Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: Luxury or necessity? Lancet Oncol 2008; 9:159-167
11. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6:603-612
12. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-Income countries. Cancer 2008; 112:461-472
13. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90
14. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): A population-based study. Lancet Oncol 2012; 13:790-801
15. Bhatia S. Disparities in cancer outcomes: Lessons learned from children with cancer. Pediatr Blood Cancer 2011; 56:994-1002
16. Chow EJ, Puumala SE, Mueller BA, et al. Childhood cancer in relation to parental race and ethnicity. Cancer 2010; 116:3045-3053
17. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6:193-203
18. Supriyadi E, Widjajanto PH, Purwanto I, et al. Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998-2009. Pediatr Blood Cancer 2011; 57: 588-593
19. Xu H, Cheng C, Devidas M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012; 30:751-757
20. Yang J, Cheng C, Devidas M, et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011; 43:237-241
21. Parkin D, Stiller C, Draper G, Bieber C. The international incidence of childhood cancer. Int J Cancer 1988; 42:511-520
22. de Camargo B, de Oliveira Santos M, Rebelo M, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population-based cancer registries. Int J Cancer 2010; 126:715-720
23. de Camargo B, de Oliveira Ferreira J, de Souza Reis R, et al. Socioeconomic status and the incidence of noncentral nervous system childhood embryonic tumours in Brazil. BMC Cancer 2011; 11:160
24. Fajardo-Gutierrez A, Juarez-Ocana S, Gonzalez-Miranda G, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: Importance of the Cancer registry (a population-based study). BMC Cancer 2007; 7:68
25. Juarez-Ocana S, Palma-Padilla V, Gonzalez-Miranda G, et al. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005). BMC Cancer 2009; 9:266
26. Henderson TO, Bhatia S, Pinto N, et al. Racial and ethnic disparities in risk and survival in children with neuroblastoma: A Children's Oncology Group Study. J Clin Oncol 2011; 29:76-82
27. Chantada GL, Qaddoumi I, Canturk S, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer 2011; 56:341-348
28. Leander C, Fu LC, Pena A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007; 49:817-819
29. Leal-Leal CA, Dilliz-Nava H, Flores-Rojo M, Robles-Castro J. First contact physicians and retinoblastoma in Mexico. Pediatr Blood Cancer 2011; 57:1109-1112
30. De Angelis C, Pacheco C, Lucchini G, et al. The experience in nicaragua: Childhood leukemia in low income countries-The main cause of late diagnosis may be 'medical delay'. Int J Pediatr 2012; 2012:129707
31. Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: Position statement of a SIOP PODC Working Group. Lancet Oncol 2011; 12:719-720
32. Bonilla M, Rossell N, Salaverria C, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009; 125:2144-2146
33. Sitaresmi MN, Mostert S, Schook RM, et al. Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: An analysis of causes and consequences. Psychooncology 2010; 19:361-367
34. Friedrich P, Ortiz R, Strait K, et al. Pediatric sarcoma in Central America. Cancer 2012. [Epub ahead of print
35. Luna-Fineman S, Barnoya M, Bonilla M, et al. Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer 2012; 58:545-550
36. Sitaresmi M, Mostert S, Gundy C, et al. Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes 2008; 6:96
37. Israëls T, van de Wetering MD, Hesseling P, et al. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 2009; 53:47-52
38. Sala A, Rossi E, Antillon F, et al. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: A perspective from Central America. Eur J Cancer 2012; 48:243-252
39. Israels T, Damen CWN, Cole M, et al. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. Eur J Cancer 2010; 46:1841-1847
40. Israëls T, Borgstein E, Jamali M, et al. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatr Blood Cancer 2009; 53:1221-1226
41. Stefan DC, Wessels G, Poole J, et al. Infection with human immunodeficiency virus-1 (HIV) among children with cancer in South Africa. Pediatr Blood Cancer 2011; 56:77-79
42. Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011; 117:4788-4795
43. Gupta S, Bonilla M, Gamero M, et al. Microbiology and mortality of pediatric febrile neutropenia in El Salvador. J Pediatr Hematol Oncol 2011; 33:276-280
44. Gupta S, Bonilla M, Valverde P, et al. Treatment-related mortality in children with acute myeloid leukaemia in Central America: Incidence, timing and predictors. Eur J Cancer 2012; 48:1363-1369
45. Caniza MA, Duenas L, Lopez B, et al A practical guide to alcohol-based hand hygiene infrastructure in a resource-poor pediatric hospital. Am J Infect Control 2009; 37:851-854
46. World Health Organization. Guide to local production: WHO-recommended handrub formulations. http://www.who.int/gpsc/5may/Guide-to-Local-Pro duction.pdf. [Accessed October 2012
47. World Health Organization. Blood safety and availability. http://www.who.int/mediacentre/factsheets/fs279/en/index.html. [Accessed October 2012
48. Needleman J, Buerhaus P, Pankratz VS, et al. Nurse staffing and inpatient hospital mortality. N Engl J Med 2011; 364:1037-1045
49. Day SW, Segovia L, Viveros P, et al. Development of the Latin American Center for pediatric oncology nursing education. Pediatr Blood Cancer 2011; 56:5-6
50. Day SW, Garcia J, Antillon F, et al A sustainable model for pediatric oncology nursing education in low-Income countries. Pediatr Blood Cancer 2012; 58:163-166
51. Day SW, McKeon LM, Garcia J, et al. Use of joint commission international standards to evaluate and improve pediatric oncology nursing care in Guatemala. Pediatr Blood Cancer 2012. [Epub ahead of print
52. Wolfe J. Recognizing a global need for high quality pediatric palliative care. Pediatr Blood Cancer 2011; 57:187-188
53. Delgado E, Barfield RC, Baker JN, et al. Availability of palliative care services for children with cancer in economically diverse regions of the world. Eur J Cancer 2010; 46:2260-2266
54. Shad A, Ashraf MS, Hafeez H. Development of palliative-care services in a developing country: Pakistan. J Pediatr Hematol Oncol 2011; 33:S62-S63
55. Ddungu H. Palliative care: What approaches are suitable in developing countries? Br J Haematol 2011; 154:728-735
56. World Health Organization. WHO Model list of essential medicines for children (3rd List, March 2011). http://www.who.int/medicines/publications/ essentialmedicines/en/index.html. [Accessed October 2012
57. International Narcotics Control Board. Report of the International Narcotics Control Board for 2010. http://www.incb.org/incb/en/publications/ annualreports/annual-report-2010.html. [Accessed October 2012
58. Hesseling P, Molyneux E, Kamiza S, et al. Endemic Burkitt lymphoma: A 28-Day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr 2009; 29:29-34
59. Traoré F, Coze C, Atteby J-J, et al. Cyclophosphamide monotherapy in children with Burkitt lymphoma: A study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 2011; 56:70-76
60. Molyneux EM, Rochford R, Griffin B, et al. Burkitt's lymphoma. Lancet 379:1234-1244
61. Karachunskiy A, Herold R, von Stackelberg A, et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 2008; 22:1144-1153
62. Hunger SP, Sung L, Howard SC. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-Income countries: A proposal. Pediatr Blood Cancer 2009; 52:559-565
63. Sitaresmi MN, Mostert S, Gundy CM, et al. Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia. Pediatr Blood Cancer 2008; 51:732-736
64. Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: A report from the Children's Oncology Group. J Clin Oncol 2012; 30:2094-2101
65. Mostert S, Sitaresmi MN, Gundy CM, et al. Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia. Arch Dis Childhood 2010; 95:20-25
66. MaseraG. Bridging the childhood cancer mortality gap between economically developed and low-Income countries. J Pediatr Hematol Oncol 2009; 31:710-712
67. Ekenze SO, Ekwunife H, Eze BI, et al. The burden of pediatric malignant solid tumors in a developing country. J Trop Pediatr 2010; 56:111-114
68. Qaddoumi I, Unal E, Diez B, et al. Web-based survey of resources for treatment and long-Term follow-up for children with brain tumors in developing countries. Childs Nerv Syst 2011; 27:1957-1961
69. Israels T, Moreira C, Scanlan T, et al. SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatr Blood Cancer 2013; 60:5-11
70. Al-Jumaily U, Ayyad O, Masarweh M, et al. Improved care of rhabdomyosarcoma in Jordan using less intensive therapy. Pediatr Blood Cancer 2013; 60:53-58
71. Rivera GK, Quintana J, Villarroel M, et al. Transfer of complex frontline anticancer therapy to a developing country: The St. Jude osteosarcoma experience in Chile. Pediatr Blood Cancer 2008; 50:1143-1146
72. Israels T, Chagaluka G, Pidini D, et al. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour. Pediatr Blood Cancer 2012; 59:636-641
73. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009; 53:42-46
74. Palma J, Mosso C, Paris C, et al. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006; 46:803-810
75. Palma J, Salas L, Carrio'n F, et al. Haploidentical stem cell transplantation for children with high-risk leukemia. Pediatr Blood Cancer 2012; 59:895-901
76. Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 2011; 154:736-744
77. Ribeiro R, Pui C-H. Treatment of acute lymphoblastic leukemia in low- And middle-Income countries: Challenges and opportunities. Leuk Lymphoma 2008; 49:373-376
78. Scanlan T, Kaijage J. From Denis Burkitt to Dar es Salaam. What happened next in East Africä - Tanzania's story. Br J Haematol 2012; 156:704-708
79. Hazin R, Qaddoumi I. Teleoncology: Current and future applications for improving cancer care globally. Lancet Oncol 2010; 11:204-210
80. Santiago TC, Jenkins JJ, Pedrosa F, et al. Improving the histopathologic diagnosis of pediatric malignancies in a low-resource setting by combining focused training and telepathology strategies. Pediatr Blood Cancer 2012; 59:221-225
81. Denburg AE, Joffe S, Gupta S, et al. Pediatric oncology research in low income countries: Ethical concepts and challenges. Pediatr Blood Cancer 2012; 58:492-497
82. Quintana Y, Patel A, Naidu P, et al. POND4Kids: A web-based pediatric cancer database for hospital-based cancer registration and clinical collaboration. In: Borycki EM, et al., editors. International perspectives in health informatics 2011. IOS Press; 2011. pp. 227-231
83. Eden T, Pui C-H, Schrappe M, et al. All children have a right to full access to treatment for cancer. Lancet 2004; 364:1121-1122